MERRIMACK PHARMACEUTICALS INC — Net Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/377568b9-419f-4be0-b92b-464dac3753e1/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-3.0M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-012087 |
| FY 2019 | $-17.3M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-010531 |
| FY 2018 | $-40.5M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006385 |
| FY 2017 | $472.0M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005246 |
| FY 2016 | $-151.7M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-003026 |
| FY 2015 | $-148.0M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-480919 |
| FY 2014 | $-83.3M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-069143 |
| FY 2013 | $-130.9M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-082294 |
| FY 2012 | $-91.3M | 2012-01-01 – 2012-12-31 | evidence 0001047469-13-003118 |
| FY 2011 | $-79.2M | 2011-01-01 – 2011-12-31 | evidence 0001047469-13-003118 |
| FY 2010 | $-50.1M | 2010-01-01 – 2010-12-31 | evidence 0001047469-13-003118 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MERRIMACK PHARMACEUTICALS INC — all facts · Revenue · Operating Income